The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 dose-escalation study of STRO-002, an antifolate receptor alpha (FRα) antibody drug conjugate (ADC), in patients with advanced, progressive platinum-resistant/refractory epithelial ovarian cancer (EOC).
 
R. Wendel Naumann
Consulting or Advisory Role - Agenus; AstraZeneca; Bristol-Myers Suibb; Clovis Oncology; Eisai; Merck Sharp & Dohme; OncoMed; Seagen; Sutro Biopharma; Tesaro/GSK
Research Funding - Bristol-Myers Squibb (Inst); Gynecologic Oncology Group (Inst); Mersana (Inst); OncoMed (Inst); Sutro Biopharma (Inst)
 
Fadi S. Braiteh
Honoraria - Amgen; ARIAD; Astellas Pharma; AstraZeneca; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Daiichi Sankyo/Lilly; Genentech/Roche; Gilead Sciences; Guardant Health; Immunomedics; Incyte; Ipsen; Lexicon; Lilly; Puma Biotechnology; Regeneron; Sanofi/Aventis; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Coherus Biosciences; Daiichi Sankyo/Lilly; Deciphera; Eisai; Exelixis; Genentech/Roche; Guardant Health; Immunomedics; Incyte; Ipsen; Lilly; Merck; Merck; Merck; Pfizer; Regeneron; Sanofi; Taiho Oncology; Taiho Oncology; Takeda
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Incyte; Insys Therapeutics; Ipsen; Lilly; Merck; Merck; Merrimack; Pfizer; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen; AstraZeneca/MedImmune; Bayer; Bayer/Onyx; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Exelixis; HERON; Incyte; Insys Therapeutics; Ipsen; Lexicon; Merrimack; Novartis; Pfizer; Regeneron; Roche/Genentech; Sanofi; Taiho Pharmaceutical; Tesaro
 
Lainie P. Martin
Consulting or Advisory Role - AstraZeneca; Elucida Oncology; GlaxoSmithKline; Sutro Biopharma
Research Funding - Agenus (Inst); AstraZeneca (Inst); Sutro bioPharma (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Erika P. Hamilton
Consulting or Advisory Role - Arvinas (Inst); AstraZeneca (Inst); Black Diamond Therapeutics (Inst); Boehringer Ingelheim (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Dantari (Inst); Deciphera (Inst); Eisai (Inst); Genentech/Roche (Inst); H3 Biomedicine (Inst); Lilly (Inst); Merck (Inst); Mersana (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Seagen (Inst); Silverback Therapeutics (Inst)
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Akeso Biopharma (Inst); Amgen (Inst); ArQule (Inst); Arvinas (Inst); AstraZeneca (Inst); Black Diamond Therapeutics (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Compugen (Inst); Curis (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Dana Farber Cancer Hospital (Inst); Deciphera (Inst); eFFECTOR Therapeutics (Inst); EMD Serono (Inst); Fochon Pharmaceuticals (Inst); Fujifilm (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); H3 Biomedicine (Inst); Harpoon (Inst); Hutchison MediPharma (Inst); Immunogen (Inst); Immunomedics (Inst); Infinity Pharmaceuticals (Inst); InventisBio (Inst); Karyopharm Therapeutics (Inst); Leap Therapeutics (Inst); Lilly (Inst); Lycera (Inst); Macrogenics (Inst); MedImmune (Inst); Merck (Inst); Mersana (Inst); Merus (Inst); Millennium (Inst); Molecular Templates (Inst); Novartis (Inst); Nucana (Inst); Olema Pharmaceuticals (Inst); OncoMed (Inst); Onconova Therapeutics (Inst); Orinove (Inst); Pfizer (Inst); PharmaMar (Inst); Plexxikon (Inst); Polyphor (Inst); Puma Biotechnology (Inst); Radius Health (Inst); Regeneron (Inst); Rgenix (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Shattuck Labs (Inst); Silverback Therapeutics (Inst); Stem CentRx (Inst); Sutro Biopharma (Inst); Syndax (Inst); Syros Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TapImmune Inc. (Inst); Tesaro (Inst); Torque (Inst); Torque (Inst); Verastem (Inst); Zenith Epigenetics (Inst); Zymeworks (Inst)
 
John Paul Diaz
Speakers' Bureau - AstraZeneca
 
Sami Diab
Stock and Other Ownership Interests - Beam; Bluebird Bio; Conatus; Editas Medicine; Fate Therapeutics; Gilead Sciences; Immunogen; Immunomedics; Novocure; Pfizer; Viking Medical
Honoraria - Agendia; AstraZeneca; Genomic Health; Lilly; Myriad Genetics; Novartis; Pfizer
Consulting or Advisory Role - Agendia; Genentech; Genomic Health; Lilly; Myriad Genetics; Novartis; Pfizer; Puma Biotechnology
Speakers' Bureau - Agendia; Genentech; Genomic Health; Lilly; Novartis; Pfizer; Puma Biotechnology
Research Funding - Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Genentech; Lilly; Novartis; Pfizer
 
Russell J. Schilder
Consulting or Advisory Role - Celsion; Clovis Oncology; Flatiron Health; ImmunoGen; Incyte
Speakers' Bureau - Pfizer
 
John William Moroney
No Relationships to Disclose
 
Denise Uyar
Research Funding - Merck
 
David M. O'Malley
Consulting or Advisory Role - Abbvie; Agenus; Ambry Genetics; AstraZeneca; Clovis Oncology; Eisai; Elevar Therapeutics; Genelux; Genentech/Roche; GlaxoSmithKline; GOG Foundation; Immunogen; Iovance Biotherapeutics; Janssen Oncology; Leap Therapeutics; Marker Therapeutics; Myriad Genetics; Novartis; Novocure; OncoQuest; Regeneron; Rubius Therapeutics; Rubius Therapeutics; Seagen; Sorrento Therapeutics; Tarveda Therapeutics; Tesaro; Translational Genomics Research Institute
Research Funding - Abbvie (Inst); Abbvie/Stemcentrx (Inst); Agenus (Inst); Ajinomoto (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Clovis Oncology (Inst); Eisai (Inst); Eisai (Inst); EMD Serono (Inst); Ergomed (Inst); Genentech/Roche (Inst); Genmab (Inst); Immunogen (Inst); Immunogen (Inst); Iovance Biotherapeutics (Inst); Janssen Research & Development (Inst); Leap Therapeutics (Inst); Merck (Inst); Mersana (Inst); PharmaMar (Inst); Regeneron (Inst); Seagen (Inst); Tesaro (Inst); TRACON Pharma (Inst)
 
Richard T. Penson
Honoraria - Abbvie; AstraZeneca; Clovis Oncology; Eisai; Genentech/Roche; Janssen Oncology; Mersana; Newlink Genetics; Sutro Biopharma; Tesaro; Vascular Biogenics
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Baxalta; Care4ward; Clovis Oncology; Eisai; Genentech; Janssen Oncology; Merck; Mersana; Sutro Biopharma; Tesaro; Vascular Biogenics
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Cerulean Pharma (Inst); Eisai (Inst); Genentech (Inst); Regeneron (Inst); Sanofi (Inst); Tesaro (Inst); Vascular Biogenics (Inst)
Patents, Royalties, Other Intellectual Property - Blackwell Publishing; BMJ; UpToDate
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Genentech; Tesaro; Vascular Biogenics
Other Relationship - Abbvie; AstraZeneca
 
Clifford DiLea
Employment - Aclara BioSciences
 
Michael Palumbo
Employment - Sutro Biopharma
Stock and Other Ownership Interests - Sutro Biopharma
 
Venita I. De Almeida
Employment - Sutro Biopharma
Stock and Other Ownership Interests - Sutro Biopharma
Patents, Royalties, Other Intellectual Property - Several patent applications through Sutro Biopharma
 
Shannon L. Matheny
Employment - Sutro Biopharma
Stock and Other Ownership Interests - Sutro Biopharma
 
Lin Lu
Employment - Sutro Biopharma
Stock and Other Ownership Interests - Nektar
 
Craig Jerome Berman
Employment - Sutro Biopharma
Stock and Other Ownership Interests - Dynavax Technologies; Halozyme; QED Therapeutics; Sutro Biopharma
Patents, Royalties, Other Intellectual Property - Halozyme; QED Therapeutics
Travel, Accommodations, Expenses - QED Therapeutics
 
Arturo Molina
Employment - Sutro Biopharma
Stock and Other Ownership Interests - Sutro Biopharma